Dynacirc and Stress urinary incontinence - a phase IV clinical study of FDA data

Summary:

Stress urinary incontinence is found among people who take Dynacirc, especially for people who are female, 50-59 old.

The phase IV clinical study analyzes which people take Dynacirc and have Stress urinary incontinence. It is created by eHealthMe based on reports of 957 people who have side effects when taking Dynacirc from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 18, 2023

957 people reported to have side effects when taking Dynacirc.
Among them, 6 people (0.63%) have Stress urinary incontinence.

What is Dynacirc?

Dynacirc has active ingredients of isradipine. eHealthMe is studying from 971 Dynacirc users for its effectiveness, alternative drugs and more.

What is Stress urinary incontinence?

Stress urinary incontinence (leak urine with things like coughing, sneezing or exercise) is found to be associated with 858 drugs and 379 conditions by eHealthMe.

Number of Dynacirc and Stress urinary incontinence reports submitted per year:

Could Dynacirc cause Stress urinary incontinence?

Gender of people who have Stress urinary incontinence when taking Dynacirc *:

female: 100 %
male: 0.0 %

Age of people who have Stress urinary incontinence when taking Dynacirc *:

Common drugs people take besides Dynacirc *:

Common side effects people have besides Stress urinary incontinence *:

High Blood Cholesterol: 5 people, 83.33%
Cataract Cortical (it affects outer part of lens): 4 people, 66.67%
Visual Acuity Reduced (reduced clearness of vision): 4 people, 66.67%
High Blood Pressure: 4 people, 66.67%
Anaemia (lack of blood): 4 people, 66.67%
Impaired Work Ability: 4 people, 66.67%
Iron Deficiency Anaemia: 4 people, 66.67%
Lobar Pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung): 4 people, 66.67%
Renal Failure Chronic (long lasting kidney dysfunction): 4 people, 66.67%
Abdominal Pain: 3 people, 50.00%

Common conditions people have *:

Cardiac Failure Congestive: 4 people, 66.67%
Osteoporosis (bones weak and more likely to break): 2 people, 33.33%
High Blood Pressure: 2 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Dynacirc and have Stress urinary incontinence?

Check whether Stress urinary incontinence is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Stress urinary incontinence and when was it recovered:

Stress urinary incontinence in Dynacirc

Expand to all the drugs that have ingredients of isradipine:

Stress urinary incontinence and drugs with ingredients of isradipine

Alternative drugs to, pros and cons of Dynacirc:

Dynacirc (971 reports)

Stress urinary incontinence treatments and more:

Stress urinary incontinence (2,332 reports)

COVID vaccines that are related to Stress urinary incontinence:

Common drugs associated with Stress urinary incontinence:

All the drugs that are associated with Stress urinary incontinence:

Stress urinary incontinence (858 drugs)

Common conditions associated with Stress urinary incontinence:

Osteoporosis: 556 reports
Multiple sclerosis: 108 reports
Depression: 106 reports

All the conditions that are associated with Stress urinary incontinence:

Stress urinary incontinence (379 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on isradipine (the active ingredients of Dynacirc) and Dynacirc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.